A cheaper, safer CBD alternative? Scientists discover new synthetic CBD analogue alleviates seizures in rats

Findings of the study are the basis of a new start-up, Syncanica, which is developing commercial applications of the new H2CBD compound

Related Articles

FormattedPicture

FOOD INGREDIENTS NEWS

27 Mar 2020 --- Therapy with icosapent ethyl, a purified stable eicosapentaenoic acid (EPA), could help prevent more than 70,000 cardiovascular events per year in US adults with a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

26 Mar 2020 --- An immediate investigation into the safety and protective functions of breast milk as it relates to the coronavirus pandemic has been initiated by the University of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Mar 2020 --- Cannabinoids, including cannabidiol (CBD), have been under the microscope as easing regulation has enabled research to flourish. According to researchers from the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Mar 2020 --- In the age of “fake news,” it is important that consumers are not misled by advertising, with global watchdogs keen to keep companies in line. With this... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Mar 2020 --- In the midst of a hazy regulatory environment surrounding cannabidiol (CBD) and its uses, many industry players are recognizing the ingredient’s potential and... Read More

trans